SYMBYX Biome, a successful medical device company trading on NASDAQ with a market cap of US$365mm, reported the following FY20 results. Sales = $167 mm; Gross margin = 62%; EBITD margin = 48%; Capex = $5mm; Debt = $8.5mm (payable in equal installments over 5 years); Book Equity = $4mm; Accounts Payable = $750,000. Assume cost of debt = 6.5%; D&A = Capex; Tax rate = 20%.What is SYMBYX's Debt Service Coverage (in x times) for FY20